Better medicines,
fast.
Better medicines,
fast.
Better medicines,
fast.
AI-driven drug formulation redefining therapeutic development.
AI-driven drug formulation redefining therapeutic development.
AI-driven drug formulation redefining therapeutic development.
Molecule in. Formulation out.
Engineered for pharma.
Used by global leaders.
Our mission
Reformulating how the world’s medicines are made.
To make drug development faster, more predictive, and more patient-centered by combining AI, automation, and deep pharmaceutical formulation expertise.
The team that helped shape modern drug delivery, now building what comes next.
The team that helped shape modern drug delivery, now building what comes next.
An AI-driven formulation platform, purpose-built for pharma.
An AI-driven formulation platform, purpose-built for pharma.
Formulations in the clinic. Partnerships with global pharma.
Formulations in the clinic. Partnerships with global pharma.
Platform
Molecule in.
Formulation out.
Molecule in.
Formulation out.
01
Molecule
A candidate molecule and target product profile to guide formulation development.
01
Molecule
A candidate molecule and target product profile to guide formulation development.
02
AI-enabled development
AI-guided workflows explore the formulation design space and identify the most promising development path.
02
AI-enabled development
AI-guided workflows explore the formulation design space and identify the most promising development path.
03
Formulation
An optimized, manufacturable formulation ready for the next stage of development.
03
Formulation
An optimized, manufacturable formulation ready for the next stage of development.
Partnerships
In partnership with the companies
bringing medicines to patients.
In partnership with the
medicines to patients.
companies
bringing
Supporting pharma partners from emerging biotechs to leading global pharma companies.
Supporting pharma partners from
emerging biotechs to leading global
pharma companies.
Supporting pharma partners from emerging biotechs to leading global pharma companies.
Supporting pharma partners from emerging biotechs to leading global pharma companies.
News & Research
Science-first. Evidence-driven.
Built for impact.
Science-first. Evidence-
driven.
Built for impact.
Company news
Life Sciences Review
Intrepid Labs received Life Sciences Review Magazine’s “Top Machine Learning Based Drug Development Company in Canada 2026” award, and was named among “Top Drug Discovery and Development Companies in Canada".
Company news
Bessemer Venture Partners
Intrepid Labs was featured in the AI-era data infrastructure market map.
Perspectives
Contract Pharma
An article highlighting Intrepid and Quotient’s partnership to accelerate drug development with artificial intelligence.
Company news
Bessemer Venture Partners
Intrepid Labs was featured in the AI-era data infrastructure market map.
Company news
Bessemer Venture Partners
Intrepid Labs was featured in the AI-era data infrastructure market map.
Company news
Life Sciences Review
Intrepid Labs received Life Sciences Review Magazine’s “Top Machine Learning Based Drug Development Company in Canada 2026” award, and was named among “Top Drug Discovery and Development Companies in Canada".
Company news
Life Sciences Review
Intrepid Labs received Life Sciences Review Magazine’s “Top Machine Learning Based Drug Development Company in Canada 2026” award, and was named among “Top Drug Discovery and Development Companies in Canada".
Perspectives
Contract Pharma
An article highlighting Intrepid and Quotient’s partnership to accelerate drug development with artificial intelligence.
Perspectives
Contract Pharma
An article highlighting Intrepid and Quotient’s partnership to accelerate drug development with artificial intelligence.
Company news
Life Sciences Review
Intrepid Labs received Life Sciences Review Magazine’s “Top Machine Learning Based Drug Development Company in Canada 2026” award, and was named among “Top Drug Discovery and Development Companies in Canada".
Company news
Bessemer Venture Partners
Intrepid Labs was featured in the AI-era data infrastructure market map.
Perspectives
Contract Pharma
An article highlighting Intrepid and Quotient’s partnership to accelerate drug development with artificial intelligence.
Company news
Bessemer Venture Partners
Intrepid Labs was featured in the AI-era data infrastructure market map.
Company news
Life Sciences Review
Intrepid Labs received Life Sciences Review Magazine’s “Top Machine Learning Based Drug Development Company in Canada 2026” award, and was named among “Top Drug Discovery and Development Companies in Canada".
Perspectives
Contract Pharma
An article highlighting Intrepid and Quotient’s partnership to accelerate drug development with artificial intelligence.
Team
Built by the people who
lead the field.
Prof. Christine Allen
Co-founder & CEO
Dr. Christine Allen is an internationally recognized expert in drug formulation and development, with over 200 peer-reviewed publications. She is a professor at the University of Toronto and a fellow of both the American Institute for Medical and Biological Engineering and the Canadian Academy of Health Sciences. She has held numerous leadership roles across academia and industry, including president of the Controlled Release Society and editor-in-chief of the Journal of Controlled Release.
Prof. Christine Allen
Co-founder & CEO
Dr. Christine Allen is an internationally recognized expert in drug formulation and development, with over 200 peer-reviewed publications. She is a professor at the University of Toronto and a fellow of both the American Institute for Medical and Biological Engineering and the Canadian Academy of Health Sciences. She has held numerous leadership roles across academia and industry, including president of the Controlled Release Society and editor-in-chief of the Journal of Controlled Release.
Let’s
talk
Partner with us to bring better medicines to patients, faster.
Let’s
talk
Partner with us to bring better medicines to patients, faster.
Let’s
talk
Partner with us to bring better medicines to patients, faster.
Let’s
talk
Partner with us to bring better medicines to patients, faster.
Ready to
formulate what’s next?
Partner with Intrepid Labs to turn promising molecules into development-ready formulations.
Stay updated
We respect your inbox. Unsubscribe anytime.
© 2026 Intrepid Labs Inc., Toronto, Canada
Ready to
formulate what’s next?
Partner with Intrepid Labs to turn promising molecules into development-ready formulations.
Stay updated
We respect your inbox. Unsubscribe anytime.
© 2026 Intrepid Labs Inc., Toronto, Canada
Ready to
formulate what’s next?
Partner with Intrepid Labs to turn promising molecules into development-ready formulations.
Stay updated
We respect your inbox. Unsubscribe anytime.
© 2026 Intrepid Labs Inc., Toronto, Canada